Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 233 |
---|---|
Genomic Coordinate (GRCh38) | g.22094005T>C |
Variant | c.755T>C |
Variant Start Position | 755 |
Location | Exon 7 |
Amino Acid Change | p.Phe252Ser |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
Variant Type | SNV |
PMID | 9106524, 16636593, 11502829, 34806794 |
Article Count | 4 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pm2, pp3, ppc |
ACMG Explanations | pm2: chrX:22112123 ref:T alt:C was not found in gnomAD exomes or genomes. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
Variant in Clinvar | Yes |
ClinVar Classification | Uncertain/conflicting |
Categories In Literature | ppc |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | X-22112123-T-C |
GnomAD Alleles | - |
DBNSFP Alleles | X-22112123-T-C |
Other Alleles | X-22112122-TTC-AGT X-22112122-TT-AG X-22112123-TC-CT X-22112123-TC-CG X-22112123-TC-CA |
Note | nan |
Warnings | - |